Research Article Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Y Josephson, Jeffrey YC Wong, Austin R Pantel, Steve Y Cho, Kenneth L Gage, Morand R Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter Carroll and Barry A Siegel DOI: 10.1158/1078-0432.CCR-20-4573 Abstract PURPOSE: Current FDA-approved imaging modalities are inadequate for localizing prostate cancer biochemical recurrence (BCR).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile